仅脓毒症、脓毒症合并COVID-19或仅COVID-19诊断患者的 demographics 与结局差异:基于ICD-10出院诊断代码的回顾性队列研究
这项回顾性队列研究纳入了学术健康系统9家医院的11,395例患者,比较仅脓毒症ICD-10代码(6,945例,60.9%)、仅COVID-19诊断(3,294例,28.9%)和脓毒症ICD-10代码+COVID-19诊断(1,153例,10.1%)三组的人口学和结局差异。结果显示,脓毒症+COVID-19组患者更年长、ICU入住率更高(59.3%)、需要通气支持比例更高(39.3%)、住院时间更长(中位9天)、院内死亡率更高(39.2%)。仅COVID-19诊断组中有相当比例患者接受了提示急性器官功能障碍的重症监护(ICU入住、插管),但未被编码为脓毒症。
要点
- 脓毒症ICD-10代码+COVID-19诊断患者院内死亡率39.2%(452/1,153),高于仅脓毒症代码的22.3%和仅COVID-19诊断的6.4%。
- 脓毒症+COVID-19组ICU入住率59.3%(684/1,153),高于仅脓毒症组的54.9%和仅COVID-19组的15%。
- 脓毒症+COVID-19组需要通气支持的比例为39.3%(453/1,153),高于仅脓毒症组的31.8%和仅COVID-19组的6.0%。
- 仅COVID-19诊断患者中有15%(1,042/6,945)入住ICU、6.0%(417/6,945)需要通气支持,但未被编码为脓毒症,提示可能存在编码不足。
- 脓毒症+COVID-19组中位住院时间9天(IQR 5-16),长于仅脓毒症组的5天和仅COVID-19组的7天。
适用人群与场景
- 因脓毒症或COVID-19住院并具有最终ICD-10出院诊断代码的成人患者,来自学术健康系统的9家医院。
- 纳入标准:最终ICD-10出院诊断代码为脓毒症、或诊断为COVID-19、或脓毒症ICD-10代码+COVID-19诊断。
研究设计与关键结果
- 研究类型:回顾性队列研究;设置:学术健康系统的9家医院;样本量:11,395例患者。
- 分组:仅脓毒症ICD-10代码6,945例(60.9%),仅COVID-19诊断3,294例(28.9%),脓毒症ICD-10代码+COVID-19诊断1,153例(10.1%)。
- 年龄:脓毒症+COVID-19组69岁(IQR 58-78),仅脓毒症组67岁(IQR 56-77),仅COVID-19组64岁(IQR 51-76)。
- 女性比例:脓毒症+COVID-19组40.3%,仅脓毒症组46.7%,仅COVID-19组49.5%。
- ICU入住率:脓毒症+COVID-19组59.3%(684/1,153),仅脓毒症组54.9%(1,810/3,297),仅COVID-19组15%(1,042/6,945)。
- 通气支持需求:脓毒症+COVID-19组39.3%(453/1,153),仅脓毒症组31.8%(1,049/3,297),仅COVID-19组6.0%(417/6,945)。
- 中位住院时间:脓毒症+COVID-19组9天(IQR 5-16),仅脓毒症组5天(IQR 3-8),仅COVID-19组7天(IQR 4-13)。
- 院内死亡率:脓毒症+COVID-19组39.2%(452/1,153),仅脓毒症组22.3%(735/3,297),仅COVID-19组6.4%(444/6,945)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在COVID-19大流行期间,同时具有脓毒症ICD-10代码和COVID-19诊断的患者是最病重的队列。
- 作者认为,仅COVID-19诊断患者中相当比例可能被编码不足,因为他们接受了提示急性器官功能障碍的重症监护(ICU入住、插管)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We analyzed whether patients with the International Classification of Diseases, 10th Edition (ICD-10) discharge diagnosis code for sepsis are different in regard to demographics and outcome variables when comparing those with sepsis only to those also diagnosed with COVID-19 or those with a COVID-19 diagnosis alone.
DESIGN: Retrospective cohort study.
SETTING: Nine hospitals in an academic health system.
PATIENTS: Patients with a final ICD-10 discharge diagnostic code for sepsis only, a diagnosis of COVID-19-only, or a final sepsis ICD-10 discharge code + a diagnosis of COVID-19 admitted to the hospital were analyzed for demographic and outcome differences between the cohorts.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 11,395 patients met inclusion criteria: 6,945 patients (60.9%) were ICD-10 sepsis code only, 3,294 patients (28.9%) were COVID-19 diagnosis-only, and 1,153 patients (10.1%) were sepsis ICD-10 code + COVID-19 diagnosis. Comparing sepsis ICD-10 code + COVID-19 diagnosis patients to sepsis ICD-10 code only and COVID-19 diagnosis-only patients, the sepsis ICD-10 code + COVID-19 diagnosis patients were: older (69 [58-78] vs 67 [56-77] vs 64 [51-76] yr), less likely to be female (40.3% vs 46.7% vs 49.5%), more frequently admitted to the ICU (59.3% [684/1,153] vs 54.9% [1,810/3,297] vs 15% [1,042/6,945]), more frequently required ventilatory support (39.3% [453/1,153] vs 31.8% [1,049/3,297] vs 6.0% [417/6,945]), had longer median hospital length of stay (9 [5,16] vs 5 [3,8] vs 7. [4,13] d), and were more likely to die in the hospital (39.2% [452/1,153] vs 22.3% [735/3,297] vs 6.4% [444/6,945]).
CONCLUSIONS: During the COVID-19 pandemic the sickest cohort of patients was those receiving an explicit ICD-10 code of sepsis + a COVID-19 diagnosis. A significant percentage of COVID-19 diagnosis-only patients appear to have been under-coded as they received a level of critical care (ICU admission; intubation) suggestive of the presence of acute organ dysfunction during their admission.
参考来源
- Gaieski DF, Tsukuda J, Maddox P, et al. Are Patients With an International Classification of Diseases, 10th Edition Discharge Diagnosis Code for Sepsis Different in Regard to Demographics and Outcome Variables When Comparing Those With Sepsis Only to Those Also Diagnosed With COVID-19 or Those With a COVID-19 Diagnosis Alone? Crit Care Explor. 2023. PMID: 37644976. doi:10.1097/CCE.0000000000000964
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。